Catalyst Wire Dossier Catalyst Wire Dossier

MF4637

MF4637 · Pronova BioPharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MF4637, covering 2018-04-04 to 2018-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients [NA]

See pricing